ACE2	Angiotensin-converting Enzyme 2
AD	Alzheimer’s disease
ANI	Asymptomatic neurocognitive impairment
ARDS	Acute respiratory distress syndrome
ARVs	Antiretroviral drugs
Aβ	Amyloid-β
BBB	Blood–brain barrier
BDNF	Brain-derived neurotrophic factor
cART	Combination antiretroviral therapy
CNS	Central nervous system
COVID-19	Coronavirus disease 2019
CVD	Cardiovascular disease
DHA	Dehydroascorbic acid
EGCG	Epigallocatechin-3-gallate
EVs	Extracellular vesicles
Exo-Cur	Exosomal curcumin
Exo-Paclitaxel	Exosomal paclitaxel
GA	Ginkgolic acid
GBLEs	Ginkgo biloba leaf extracts
HAD	HIV-associated dementia
HAND	HIV-associated neurocognitive disorders
HDIVC	High-dose intravenous vitamin
I.P.	Intraperitoneal
I.V.	Intravenous
LPS	Lipopolysaccharide
MS	Multiple sclerosis
PD	Parkinson’s disease
PIs	Protease inhibitors
PLWHA	People living with HIV/AIDS
RCT	Randomized controlled trial
SARS-CoV-2	Severe acute respiratory syndrome coronavirus 2
TIMBD	4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}